Cancer

Research by Mingjian Shi, PhD, left, Jonathan Mosley, MD, PhD, Kerry Schaffer, MD, MSCI, and colleagues found that polygenic risk score does not improve prediction of aggressive prostate cancer.
March 16, 2023

Study evaluates polygenic risk score for prostate cancer risk prediction

A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.

By Leigh MacMillan
March 16, 2023

Eng stresses need for clinical trial support at cancer forum

Vanderbilt’s Cathy Eng, MD, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum.

By Tom Wilemon
March 7, 2023

Nicole Kidman and Keith Urban gift supports breast cancer clinical trials at Vanderbilt-Ingram Cancer Center

Nicole Kidman and Keith Urban have made a generous financial gift to Vanderbilt-Ingram Cancer Center in support of clinical trials for new and better therapies for breast cancer.

By Tom Wilemon
March 2, 2023

Eng invited to White House Cancer Moonshot forum

Vanderbilt’s Cathy Eng, MD, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum.

By Tom Wilemon
February 23, 2023

Trial seeks to expand therapies for biliary cancers

A Vanderbilt clinical trial seeks to optimize the effect of immunotherapies for patients with biliary tract cancers who have already progressed on first-line therapy.

By Tom Wilemon
February 16, 2023

Breast cancer genetics: new insights

Largest genetic study of breast cancer to date identifies 222 genetic risk loci, 137 genes and multiple signaling pathways associated with risk, providing important new insights.

By Leigh MacMillan
February 16, 2023

Patient undergoes novel therapy to treat pancreatic cancer

Maudean Armour of Clarksville, Tennessee, is the first patient in Tennessee to undergo intraoperative radiotherapy for pancreatic cancer — a new technology that targets any remaining cancer cells with electrons during surgery.
By Tom Wilemon
February 16, 2023

Tindle authors NCI guidance on treatment of cancer patients who smoke

Vanderbilt's Hilary Tindle, MD, MPH, was one of the key contributors to the new Tobacco Control Monograph from the National Cancer Institute.
By Tom Wilemon
February 9, 2023

‘Biopsy Queen’ reaches milestone number of procedures

Vanderbilt-Ingram Cancer Center's Krista Kuhnert-Gainer, ACNP has performed more than 20,000 bone marrow biopsies since 1996.
By Tom Wilemon
February 9, 2023

Vanderbilt-Ingram joins CancerLinQ quality initiative

Vanderbilt-Ingram Cancer Center is now participating in CancerLinQ, a technology initiative focused on improving patient care that tracks quality metrics in real time.
By Tom Wilemon
February 2, 2023

Researchers clarify role of blood cell mutations in disease

Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells.
By Bill Snyder
January 19, 2023

Pediatric surgeon’s medical career began with a lucky catch

While he was in medical school, pediatric surgeon Joseph Fusco, MD, learned in an unusual way that he had thyroid cancer.
By Jessica Pasley
January 19, 2023

Surgeons target pancreatic cancer with electrons using new technology

Vanderbilt surgeons recently treated a pancreatic cancer patient using IntraOp Mobetron IORT with electrons — the first surgery performed in Tennessee with this new technology utilizing intraoperative radiotherapy in the operating room.
By Tom Wilemon
1 … 14 15 16 17 18 … 72